BioSpace News Archive

IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market opens on Friday, February 4th.

Pharma Two B Ltd. today announced that it will host a key opinion leader (KOL) event to discuss the positive results from the pivotal Phase III Study of P2B001 in early Parkinson’s Disease (PD) on Thursday, January 27, 2022 from 11am – 12pm Eastern Time.

VT1021 Selected by Global Coalition for Adaptive Research (GCAR) for Inclusion in Its GBM AGILE Phase 2-3 Adaptive Platform Trial for Patients with Glioblastoma.

BioTheryX, Inc. today announced the appointment of Sahm Nasseri as Chief Business Officer.

CASI Pharmaceuticals, Inc. announced today, that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its partner BioInvent International AB, for BI-1206, an investigational anti-FcyRllB antibody, for the treatment of follicular lymphoma (FL), the most common form of slow-growing Non-Hodgkin lymphoma (NHL).

Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex ® Scoring Balloon.

ADC Therapeutics SA today announced it will host a webcast highlighting its ADC platform and solid tumor pipeline on Tuesday, February 8, from 9:00 to 11:00 a.m. ET.

4D pharma plc today announced that it will host a virtual Key Opinion Leader (KOL) event to review previously disclosed positive topline results from Part A of its Phase I/II trial of MRx-4DP0004 for the treatment of asthma.

Xilio Therapeutics, Inc. today announced that the first patient has been dosed in the company’s Phase 1/2 clinical trial evaluating XTX202 for the treatment of solid tumors.

Graybug Vision, Inc. announced the hiring of six new employees who will enhance Graybug’s Research & Development, Regulatory Affairs and Program Management capabilities, as the Company further builds momentum behind its pipeline in 2022.